HopeStage
Back to all studies
RecruitingNCT07031544

Deep brain stimulation for difficult-to-treat obsessive-compulsive symptoms

About this title

Efficacy and Influencing Factors of ALIC-NAc Deep Brain Stimulation in Treatment-Refractory Obsessive-Compulsive Disorder

Read the official source — NCT07031544
Device studyAges 18–65ChinaOCD
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations
Guangzhou and 9 more locationsSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: December 14, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
60
Sponsor
Shanghai Mental Health Center
Sponsor type
Hospital / academic medical center
Study type
Device
Intervention type
Device
Locations
China
Age range
From 18 Years to 65 Years
Official registry ID
NCT07031544
Official title
Show the full official title

Efficacy and Influencing Factors of Combined Anterior Limb of Internal Capsule and Nucleus Accumbens Deep Brain Stimulation in Treatment-Refractory Obsessive-Compulsive Disorder

Recruitment & locations

Currently recruiting

Guangzhou · Shijiazhuang · Xinxiang

6 more locations
  • Nanchang
  • Taiyuan
  • Mianyang
  • Shanghai
  • Tianjin
  • Tianjing

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Shanghai Mental Health Center, a hospital or academic medical center.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies